Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Clear cell renal cell carcinoma (ccRCC) with hemangioblastoma-like features: a previously unreported pattern of ccRCC with possible clinical significance.

Montironi R, Lopez-Beltran A, Cheng L, Galosi AB, Montorsi F, Scarpelli M.

Eur Urol. 2014 Nov;66(5):806-10. doi: 10.1016/j.eururo.2014.04.022. Epub 2014 May 2.

PMID:
24821578
2.

Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.

Dhakal HP, McKenney JK, Khor LY, Reynolds JP, Magi-Galluzzi C, Przybycin CG.

Am J Surg Pathol. 2016 Feb;40(2):141-54. doi: 10.1097/PAS.0000000000000583.

PMID:
26752401
3.

PAX2(-)/PAX8(-)/inhibin A(+) immunoprofile in hemangioblastoma: A helpful combination in the differential diagnosis with metastatic clear cell renal cell carcinoma to the central nervous system.

Carney EM, Banerjee P, Ellis CL, Albadine R, Sharma R, Chaux AM, Burger PC, Netto GJ.

Am J Surg Pathol. 2011 Feb;35(2):262-7. doi: 10.1097/PAS.0b013e3182064d11.

PMID:
21263247
4.

Diagnostic use of PAX8, CAIX, TTF-1, and TGB in metastatic renal cell carcinoma of the thyroid.

Cimino-Mathews A, Sharma R, Netto GJ.

Am J Surg Pathol. 2011 May;35(5):757-61. doi: 10.1097/PAS.0b013e3182147fa8.

5.

Sporadic hemangioblastoma of the kidney with PAX2 and focal CD10 expression: report of a case.

Jiang JG, Rao Q, Xia QY, Tu P, Lu ZF, Shen Q, Zhang RS, Yu B, Zhou XJ, Shi SS, Shi QL.

Int J Clin Exp Pathol. 2013 Aug 15;6(9):1953-6. eCollection 2013.

6.

Sporadic renal hemangioblastoma with CA9, PAX2 and PAX8 expression: diagnostic pitfall in the differential diagnosis from clear cell renal cell carcinoma.

Kuroda N, Agatsuma Y, Tamura M, Martinek P, Hes O, Michal M.

Int J Clin Exp Pathol. 2015 Feb 1;8(2):2131-8. eCollection 2015.

7.

PAX8 is expressed in the majority of renal epithelial neoplasms: an immunohistochemical study of 223 cases using a mouse monoclonal antibody.

Hu Y, Hartmann A, Stoehr C, Zhang S, Wang M, Tacha D, Montironi R, Lopez-Beltran A, Cheng L.

J Clin Pathol. 2012 Mar;65(3):254-6. doi: 10.1136/jclinpath-2011-200508. Epub 2011 Dec 1.

PMID:
22135028
8.

Clear Cell Renal Cell Carcinoma With Borderline Features of Clear Cell Papillary Renal Cell Carcinoma: Combined Morphologic, Immunohistochemical, and Cytogenetic Analysis.

Williamson SR, Gupta NS, Eble JN, Rogers CG, Michalowski S, Zhang S, Wang M, Grignon DJ, Cheng L.

Am J Surg Pathol. 2015 Nov;39(11):1502-10. doi: 10.1097/PAS.0000000000000514.

PMID:
26457355
9.

PAX8 expression in sporadic hemangioblastoma of the kidney supports a primary renal cell lineage: implications for differential diagnosis.

Zhao M, Williamson SR, Yu J, Xia W, Li C, Zheng J, Zhu Y, Sun K, Wang Z, Cheng L.

Hum Pathol. 2013 Oct;44(10):2247-55. doi: 10.1016/j.humpath.2013.05.007. Epub 2013 Jul 10.

PMID:
23849894
10.

Expression of brachyury in hemangioblastoma: potential use in differential diagnosis.

Barresi V, Vitarelli E, Branca G, Antonelli M, Giangaspero F, Barresi G.

Am J Surg Pathol. 2012 Jul;36(7):1052-7. doi: 10.1097/PAS.0b013e31824f4ce3.

PMID:
22446946
11.

Metastasis of renal cell carcinoma to central nervous system hemangioblastoma in two patients with von Hippel-Lindau disease.

Hamazaki S, Nakashima H, Matsumoto K, Taguchi K, Okada S.

Pathol Int. 2001 Dec;51(12):948-53.

PMID:
11844068
12.

Clear cell renal cell carcinoma with hemangioblastoma-like features: A recently described pattern with unusual immunohistochemical profile.

Sancheti S, Menon S, Mukherjee S, Arun I.

Indian J Pathol Microbiol. 2015 Jul-Sep;58(3):354-5. doi: 10.4103/0377-4929.162898.

13.

Immunohistochemical markers to distinguish between hemangioblastoma and metastatic clear-cell renal cell carcinoma in the brain: utility of aquaporin1 combined with cytokeratin AE1/AE3 immunostaining.

Weinbreck N, Marie B, Bressenot A, Montagne K, Joud A, Baumann C, Klein O, Vignaud JM.

Am J Surg Pathol. 2008 Jul;32(7):1051-9. doi: 10.1097/PAS.0b013e3181609d7d.

PMID:
18496143
14.

Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.

Waldert M, Klatte T, Haitel A, Ozsoy M, Schmidbauer J, Marberger M, Remzi M.

Eur Urol. 2010 Apr;57(4):661-5. doi: 10.1016/j.eururo.2009.05.009. Epub 2009 May 18.

PMID:
19477583
15.

High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.

Wu XR, Sha JJ, Liu DM, Chen YH, Yang GL, Zhang J, Chen YY, Bo JJ, Huang YR.

Eur J Surg Oncol. 2013 Jan;39(1):100-6. doi: 10.1016/j.ejso.2012.10.004. Epub 2012 Oct 24.

PMID:
23102595
16.

Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma.

Sirohi D, Smith SC, Ohe C, Colombo P, Divatia M, Dragoescu E, Rao P, Hirsch MS, Chen YB, Mehra R, Amin MB.

Hum Pathol. 2017 Sep;67:134-145. doi: 10.1016/j.humpath.2017.07.006. Epub 2017 Jul 15.

PMID:
28716439
17.

Metastases to hemangioblastomas in von Hippel-Lindau disease.

Jarrell ST, Vortmeyer AO, Linehan WM, Oldfield EH, Lonser RR.

J Neurosurg. 2006 Aug;105(2):256-63.

PMID:
17219831
18.

Peripheral hemangioblastoma: clinicopathologic characterization in a series of 22 cases.

Doyle LA, Fletcher CD.

Am J Surg Pathol. 2014 Jan;38(1):119-27. doi: 10.1097/PAS.0b013e3182a266c1.

PMID:
24145646
20.

[Clinicopathologic characteristics of sporadic renal hemangioblastoma].

Guo J, Li L, Zhao LH, Li Y, Wang LS, Xiao L, Zhang RY.

Zhonghua Bing Li Xue Za Zhi. 2013 Oct;42(10):679-82. Review. Chinese.

PMID:
24433731

Supplemental Content

Support Center